Suppr超能文献

在肯尼亚西部侵袭性乳腺癌中,肿瘤浸润白细胞密度与肿瘤分级和分子亚型无关。

Tumor infiltrating leukocyte density is independent of tumor grade and molecular subtype in aggressive breast cancer of Western Kenya.

作者信息

Sawe Rispah T, Mining Simeon K, Ofulla Ayub V, Patel Kirtika, Guyah Bernard, Chumba David, Prosperi Jenifer R, Kerper Maggie, Shi Zonggao, Sandoval-Cooper Mayra, Taylor Katherine, Badve Sunil, Stack M Sharon, Littlepage Laurie E

机构信息

Department of Immunology, Moi University, College of Health Sciences, School of Medicine, P.O.Box 4606-30100, Eldoret, Kenya.

Department of Biomedical Sciences, School of Public Health and Community Development, Maseno University, Kisumu, Kenya.

出版信息

Trop Med Health. 2017 Aug 4;45:19. doi: 10.1186/s41182-017-0059-4. eCollection 2017.

Abstract

BACKGROUND

Tumors commonly are infiltrated by leukocytes, or tumor infiltrating leukocytes (TILs). It remains unclear, however, if the density and type of individual TILs has a direct or simply correlative role in promoting poor prognosis in breast cancer patients. Breast cancer in Kenyan women is aggressive with presentation at a young age, with advanced grade (grade III), large tumor size (>2.0 cm), and poor prognosis. We previously observed that the tumors were predominantly estrogen receptor positive (ER+) but also included both a high percentage of triple negative tumors and also increased immune cell infiltration within the tumors. We used breast tumor tissues from each patient to make tissue microarrays that were then stained for leukocyte and myeloid markers including CD4, CD8, CD20, CD25, CD68, and CD163 using immunohistochemical techniques. The immune cell infiltration into the cancer tissue included increased numbers of macrophages (CD68+), helper T cells (CD4+), and CD25+ lymphocytes compared to benign tissue.

RESULTS

This study characterized the grade, molecular subtypes, and proliferation index of these tumors and determined if TIL density was enriched across any of these factors. We analyzed 49 malignant patient tissue samples for this study. The patient population had a mean age of 51.9 years. The tumors analyzed were heterogeneous by grade: grade I (6%), grade II (47%), and grade III (39%). Most patients presented with large tumors (>2.0 cm) (69%). We classified the tumors into molecular subtypes based on clinical marker expression. Based on this analysis, the molecular subtype distribution was heterogeneous with luminal B (41%), basal/triple negative (TN) (37%), luminal A (14%) and HER2 (8%) breast cancer subtypes. While the basal/TN subtype had a much higher proliferative index (Ki-67+) than did the other molecular subtypes, we did not see a significant correlation between TIL density and either subtype or tumor grade. Therefore, TIL density is independent of molecular subtype and grade.

CONCLUSION

This study identified a Kenyan patient cohort that develops large, high-grade tumors primarily of the luminal B and basal molecular subtypes. After analyzing the TILs within these tumors, we found that immune cell infiltration of these tumors correlated with increased proliferation but not grade or molecular subtype. Future research is required to determine if the aberrant recruitment of TILs to tumors contributes to cancer progression and response to cancer treatments.

摘要

背景

肿瘤通常会被白细胞浸润,即肿瘤浸润白细胞(TILs)。然而,个体TILs的密度和类型在促进乳腺癌患者预后不良方面是具有直接作用还是仅仅存在相关性仍不清楚。肯尼亚女性的乳腺癌具有侵袭性,发病年龄较轻,肿瘤分级高(III级),肿瘤体积大(>2.0 cm),预后较差。我们之前观察到,这些肿瘤主要为雌激素受体阳性(ER+),但也包括高比例的三阴性肿瘤,并且肿瘤内免疫细胞浸润增加。我们使用每位患者的乳腺肿瘤组织制作组织微阵列,然后采用免疫组织化学技术对包括CD4、CD8、CD20、CD25、CD68和CD163在内的白细胞和髓系标志物进行染色。与良性组织相比,浸润到癌组织中的免疫细胞包括巨噬细胞(CD68+)、辅助性T细胞(CD4+)和CD25+淋巴细胞数量增加。

结果

本研究对这些肿瘤的分级、分子亚型和增殖指数进行了特征分析,并确定TIL密度是否在这些因素中的任何一个上富集。我们分析了49例恶性患者组织样本用于本研究。患者群体的平均年龄为51.9岁。所分析的肿瘤在分级上具有异质性:I级(6%)、II级(47%)和III级(39%)。大多数患者表现为大肿瘤(>2.0 cm)(69%)。我们根据临床标志物表达将肿瘤分为分子亚型。基于此分析,分子亚型分布具有异质性,包括管腔B型(41%)、基底/三阴性(TN)型(37%)、管腔A型(14%)和HER2型(8%)乳腺癌亚型。虽然基底/TN亚型的增殖指数(Ki-67+)比其他分子亚型高得多,但我们未发现TIL密度与亚型或肿瘤分级之间存在显著相关性。因此,TIL密度独立于分子亚型和分级。

结论

本研究确定了一个肯尼亚患者队列,该队列主要发生管腔B型和基底分子亚型的大的、高级别肿瘤。在分析这些肿瘤内的TILs后,我们发现这些肿瘤的免疫细胞浸润与增殖增加相关,但与分级或分子亚型无关。未来需要开展研究以确定TILs异常募集到肿瘤是否会促进癌症进展以及对癌症治疗的反应。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0105/5543450/4e124c2223e4/41182_2017_59_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验